77 related articles for article (PubMed ID: 27035764)
1. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-150 Inhibits Cell Invasion and Migration and Is Downregulated in Human Osteosarcoma.
Li X; Chen L; Wang W; Meng FB; Zhao RT; Chen Y
Cytogenet Genome Res; 2015; 146(2):124-135. PubMed ID: 26361218
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells.
He Y; Yu B
Exp Ther Med; 2017 May; 13(5):2003-2011. PubMed ID: 28565800
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of circ_0076684 in osteosarcoma facilitates malignant processes by mediating miRNAs/CUX1.
Cai P; Fu X; Li X; Zhao W
J Orthop Surg Res; 2024 Apr; 19(1):260. PubMed ID: 38659042
[TBL] [Abstract][Full Text] [Related]
5. MiR-29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6.
Zhu K; Liu L; Zhang J; Wang Y; Liang H; Fan G; Jiang Z; Zhang CY; Chen X; Zhou G
Protein Cell; 2016 Jun; 7(6):434-44. PubMed ID: 27230400
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200b acts as a tumor suppressor in osteosarcoma via targeting ZEB1.
Li Y; Zeng C; Tu M; Jiang W; Dai Z; Hu Y; Deng Z; Xiao W
Onco Targets Ther; 2016; 9():3101-11. PubMed ID: 27307751
[TBL] [Abstract][Full Text] [Related]
7. Exosome microRNA-22 inhibiting proliferation, migration and invasion through regulating Twist1/CADM1 axis in osteosarcoma.
Ruan Q; Wang C; Wu Y; Zhu Q
Sci Rep; 2024 Jan; 14(1):761. PubMed ID: 38191892
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-218 inhibits cell proliferation, migration and invasion by targeting Runt-related transcription factor 2 (Runx2) in human osteosarcoma cells.
Guo Q; Ma J; Wu J
Regen Ther; 2021 Dec; 18():508-515. PubMed ID: 34977284
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA CircSATB2 facilitates osteosarcoma progression through regulating the miR-661/FUS-mediated mRNA of ZNFX1.
Wang Z; She D; Liu L; Hua X; Zhu H; Yu L; Wang H; Zhu Y; Fan G; Wang Y; Xu M; Zhou G
Cell Signal; 2024 Feb; 114():110977. PubMed ID: 37984605
[TBL] [Abstract][Full Text] [Related]
10. MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2.
Pang J; Dai L; Zhang C; Zhang Q
J Healthc Eng; 2021; 2021():6974225. PubMed ID: 34257854
[TBL] [Abstract][Full Text] [Related]
11. Loss of Runx2 sensitises osteosarcoma to chemotherapy-induced apoptosis.
Roos A; Satterfield L; Zhao S; Fuja D; Shuck R; Hicks MJ; Donehower LA; Yustein JT
Br J Cancer; 2015 Nov; 113(9):1289-97. PubMed ID: 26528706
[TBL] [Abstract][Full Text] [Related]
12. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.
San Martin IA; Varela N; Gaete M; Villegas K; Osorio M; Tapia JC; Antonelli M; Mancilla EE; Pereira BP; Nathan SS; Lian JB; Stein JL; Stein GS; van Wijnen AJ; Galindo M
J Cell Physiol; 2009 Dec; 221(3):560-71. PubMed ID: 19739101
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-124 acts as a tumor-suppressive miRNA by inhibiting the expression of Snail2 in osteosarcoma.
Huang J; Liang Y; Xu M; Xiong J; Wang D; Ding Q
Oncol Lett; 2018 Apr; 15(4):4979-4987. PubMed ID: 29552134
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-493 inhibits the proliferation and invasion of osteosarcoma cells through directly targeting specificity protein 1.
Qian M; Gong H; Yang X; Zhao J; Yan W; Lou Y; Peng D; Li Z; Xiao J
Oncol Lett; 2018 May; 15(5):8149-8156. PubMed ID: 29740498
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.
Sadikovic B; Thorner P; Chilton-Macneill S; Martin JW; Cervigne NK; Squire J; Zielenska M
BMC Cancer; 2010 May; 10():202. PubMed ID: 20465837
[TBL] [Abstract][Full Text] [Related]
16. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.
Zhang X; Wu H; Dobson JR; Browne G; Hong D; Akech J; Languino LR; Stein GS; Lian JB
J Cell Biochem; 2015 Sep; 116(9):2098-108. PubMed ID: 25808168
[TBL] [Abstract][Full Text] [Related]
17. Isovitexin Suppresses Cancer Stemness Property And Induces Apoptosis Of Osteosarcoma Cells By Disruption Of The DNMT1/miR-34a/Bcl-2 Axis.
Liang X; Xu C; Cao X; Wang W
Cancer Manag Res; 2019; 11():8923-8936. PubMed ID: 31686915
[TBL] [Abstract][Full Text] [Related]
18. MiR-383 sensitizes osteosarcoma cells to bortezomib treatment via down-regulating PSMB5.
Wang H; Bai C; Dang X; Wang H
Mol Biol Rep; 2024 Jan; 51(1):170. PubMed ID: 38252234
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation.
Jiang H; Zhao X; Zang J; Wang R; Gao J; Chen J; Yu T
Front Pharmacol; 2024; 15():1399625. PubMed ID: 38720781
[No Abstract] [Full Text] [Related]
20. CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value.
Xu B; Yang T; Wang Z; Zhang Y; Liu S; Shen M
Cancer Manag Res; 2018; 10():4871-4880. PubMed ID: 30425578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
